Abraaj eyes IPO for Egypt health business
Dubai, October 15, 2012
Abraaj Capital, the Middle East's largest private equity firm, is considering selling shares in its Egyptian medical laboratories business in 2013, its chief executive said on Monday.
The Dubai-based firm's portfolio company, Al Borg Laboratories, entered into a merger agreement with Al Mokhtabar Laboratories in August to create Integrated Diagnostics Holding, the biggest medical laboratories business in the region.
Before that deal, Abraaj owned about 99 percent of Al Borg.
Abraaj expects to sell part of its 50-percent stake in Integrated Holding in the IPO and the remaining stake to a strategic investor, Chief Executive Mustafa Abdul-Wadood told Reuters in an interview.
"An IPO (of Integrated Diagnostics Holding) seems to be the most natural exit route for us. The company has been self funded for some time and the IPO will guarantee funding for its future growth," Abdul-Wadood added.
"We keep our options open for the listing. There has to be an international aspect to that. I can think of London as one option," he said.
Abraaj struck a deal to buy emerging market fund manager Aureos Capital in February, creating an entity with approximately $7.5 billion in assets under management.
Dubai-based Abraaj has been pushing to expand its geographical footprint in emerging markets. It owns stakes in Egypt's Orascom Construction, budget carrier Air Arabia and supermarket chain Spinneys. - Reuters
More Finance & Capital Market Stories
- Gulf stocks surge as Fed tapering adds fuel to fire
- SABB launches graduates programme
- NBAD names key official for Hong Kong
- Commercial Bank of Dubai obtains $450m loan
- EFG Hermes names group co-chief
- Islamic bond issuance in GCC picking up
- Kuwait budget surplus likely to hit $42.4bn
- Bahrain banking sector on road to recovery
- GCC banks' outlook stable, says report
- GBSA panel names new chairperson